Abstract

The development and maintenance of retinal vasculature require a precise balance between pro-angiogenic and anti-angiogenic factors. However, mechanisms underlying normal homeostasis of retinal vasculature and pathological changes of disrupted retinal vessel development are not fully understood. Recent studies of the low-density lipoprotein receptor-related protein 5 (LRP5) and the very low-density lipoprotein receptor (VLDLR) mutant mice indicate that LRP5 mediates a pro-angiogenic signal while VLDLR mediates an anti-angiogenic signal in retinal vasculature. Mice with a loss of LRP5 display underdeveloped intraretinal vasculature associated with endothelial cell (EC) clustering and failed EC migration into deep retinal layers. In contrast, VLDLR knockout mice show overgrown intraretinal vasculature and subretinal neovascularization. To understand the mechanisms for the opposite retinal vascular abnormalities between LRP5 and VLDLR mutant mice and to test how a loss of LRP5 perturbs subretinal neovascularization caused by a loss of VLDLR, we have generated and characterized the retinal vasculature in LRP5/VLDLR double knockout (DKO) mice. Our data show that DKO mice develop substantial EC clustering without subretinal neovascularization. The absence of subretinal neovascularization in DKO mice is associated with inhibited migration of ECs into the photoreceptor cell layer. In addition, the transcription level of Slc38a5, which encodes a Müller cell specific glutamine transporter, is significantly reduced in DKO mice, similar to previously reported changes in LRP5 single knockout mice. Thus, LRP5 signaling is a prerequisite for neovascularization in VLDLR knockout mice. LRP5 may be an effective target for inhibiting intraretinal neovascularization.

Highlights

  • Retinal vascular disorders remain one of the leading causes of blindness

  • Previous studies have demonstrated that a loss of lipoprotein receptor-related protein 5 (LRP5) causes underdeveloped retinal vasculature, whereas a lack of very low-density lipoprotein receptor (VLDLR) leads to retinal neovascularization [12,13,14,15,18]

  • This work reveals that Lrp5-/- Vldlr-/- double knockout (DKO) mice show no subretinal neovascularization, which occurred in Vldlr-/- mice; the DKO mice develop incomplete retinal vasculature, resembling the phenotype of Lrp5-/- mice (Figure 7)

Read more

Summary

Introduction

Retinal vascular disorders remain one of the leading causes of blindness. It is necessary to explore new effective targets other than VEGF for inhibiting neovascularization caused by diabetic retinopathy, retinopathy of prematurity (ROP) and agerelated macular degeneration (AMD). Wnt signaling is one of the key regulators in retinal vasculature development [1]. The low-density lipoprotein receptor-related protein 5 (LRP5), a member of the low-density lipoprotein (LDL) receptor family, is a co-receptor of the Wnt ligand-receptor complex that consists of Norrin and Frizzled 4 (FZD4) as well as an auxiliary membrane protein tetraspanin, Tspan. Loss-of-function mutations in Norrin, FZD4, LRP5 and Tspan all cause familial exudative vitreoretinopathy (FEVR) in humans [2,3,4,5,6,7]. Hypovascularization of human and mouse retinas caused by mutations of these genes demonstrates the essential roles of these molecules in retinal vasculature development and homeostasis. Norrin, FZD4, LRP5 and Tspan may be effective clinical targets for inhibiting neovascularization in the retina [9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call